NPS Pharmaceuticals Inc
Business Identifier:
Public Profile:
NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of specialty therapeutics for gastrointestinal and endocrine disorders. The company is advancing two late-stage programs to restore or replace biological function, including GATTEX (teduglutide), which is in Phase 3 clinical development for parenteral dependent short bowel syndrome; and NPSP558 (parathyroid hormone 1-84 [rDNA origin] injection) that is in Phase 3 clinical development as a hormone therapy for hypoparathyroidism. It complements its internal programs with strategic partnerships with Amgen, GlaxoSmithKline, Kyowa Kirin, and Nycomed. The company was founded in 1986 and is headquartered in Bedminster, New Jersey.


 Synopsis: Tech Seeker Business Condition
Year Founded 1986 Sector N/A
Employment 63 Industry N/A
Company Type Public Stock Symbol NASDAQ:NPSP